tiprankstipranks
Biorestorative Therapies, Inc. (BRTX)
NASDAQ:BRTX
US Market
BRTX
BioRestorative Therapies
RESEARCH TOOLSreports

BioRestorative Therapies (BRTX) Financial Statements

Compare
233 Followers

BioRestorative Therapies Financial Overview

BioRestorative Therapies's market cap is currently $6.40M. The company's EPS TTM is $-0.361; its P/E ratio is -0.75; BioRestorative Therapies is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 359.70K$ 401.00K$ 145.80K$ 119.80K$ 46.00K
Gross Profit$ 335.86K$ 372.93K$ 145.80K$ 119.80K$ 46.00K
Operating Income$ -15.65M$ -11.56M$ -15.22M$ -18.97M$ -26.31M
EBITDA$ -15.65M$ -11.37M$ -14.97M$ -18.74M$ -26.22M
Net Income$ -14.24M$ -8.98M$ -10.42M$ -13.22M$ -44.30M
Balance Sheet
Cash & Short-Term Investments$ 2.95M$ 10.73M$ 11.07M$ 14.75M$ 21.03M
Total Assets$ 4.08M$ 12.28M$ 12.61M$ 16.43M$ 22.45M
Total Debt$ 0.00$ 0.00$ 162.32K$ 301.64K$ 670.70K
Net Debt$ -1.51M$ -547.89K$ -722.06K$ -1.41M$ -20.36M
Total Liabilities$ 3.72M$ 3.75M$ 2.61M$ 6.14M$ 856.50K
Stockholders' Equity$ 356.74K$ 8.53M$ 10.00M$ 10.29M$ 21.60M
Cash Flow
Free Cash Flow$ -10.79M$ -8.34M$ -6.60M$ -6.35M$ -3.36M
Operating Cash Flow$ -10.79M$ -8.23M$ -6.43M$ -5.91M$ -3.33M
Investing Cash Flow$ 8.90M$ 514.53K$ 3.25M$ -13.40M$ -30.66K
Financing Cash Flow$ 2.85M$ 7.38M$ 2.35M$ 0.00$ 21.32M
Currency in USD

BioRestorative Therapies Earnings and Revenue History

Income Statement >

BioRestorative Therapies Debt to Assets

Balance Sheet >

BioRestorative Therapies Cash Flow

Cash Flow >

BioRestorative Therapies Forecast EPS vs Actual EPS

Earnings >